Results 1 to 10 of about 11,423 (215)

Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia

Dermatology and Therapy, 2023
Introduction This study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA) and analyzed the factors associated with minoxidil discontinuation.
Shadi Zari
exaly   +3 more sources

New Target for Minoxidil in the Treatment of Androgenetic Alopecia

Drug Design, Development and Therapy, 2023
Yuqing Shen,1 Yuqi Zhu,1 Li Zhang,1 Jiayi Sun,1 Bo Xie,2 Hongyan Zhang,2 Xiuzu Song2 1Department of Dermatology, Hangzhou Third People’s Hospital, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Dermatology ...
Shen Y, Zhu Y, Zhang L, Sun J, Xie B, Zhang H, Song X   +6 more
doaj   +2 more sources

Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation

Acta Dermato-Venereologica
Topical minoxidil is the mainstay of treatment for androgenic alopecia and is also used off-label for other forms of hair loss. Despite its efficacy and favourable safety profile, the use of minoxidil is associated with various side effects, the most ...
Alexandra Junge, Susanne Radonjic-Hoesli, Simon Bossart, Dagmar Simon, Pierre de Viragh, Robert E. Hunger, Kristine Heidemeyer, S. Morteza Seyed Jafari   +7 more
doaj   +2 more sources

Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy in female pattern hair loss–A randomized controlled trial in Chinese females

Photodiagnosis and Photodynamic Therapy
Objectives: To investigate the effectiveness and safety of combination of 655 nm low level laser helmet device with topical 2 % minoxidil solution at FPHL in Chinese population.
Xianhong Yang, Rui Qiao, Wei Cheng, Xuemei Lan, Yufen Li, Yiqun Jiang   +5 more
doaj   +2 more sources

Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review

Dermatology and Therapy
The minimal adverse-effect profile and positive clinical response of low-dose oral minoxidil (LDOM) have recently caused the drug to gain popularity for the treatment of hair disorders in adults.
Kimberly N. Williams, Chrislene T. Y. Olukoga, Antonella Tosti   +2 more
doaj   +2 more sources

Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial

Journal of Dermatological Treatment, 2023
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram, Rashmi Kumari, Sivaranjini Ramassamy   +2 more
doaj   +2 more sources

Minoxidil ameliorates myelodysplastic syndrome by targeting Wnt4 while sparing normal hematopoiesis [PDF]

Cell Communication and Signaling
Background Hematopoietic stem cells (HSCs) maintain blood production via tightly regulated differentiation. Disruptions at this level can lead to myelodysplastic syndromes (MDS), characterized by ineffective hematopoiesis and marrow failure.
Xiaoling Shi, Yushi Liu, Lejun Huang, Yuxin Ou, Xinyu Chen, Yiming Ling, Yiyue Zhang, Qing Lin   +7 more
doaj   +2 more sources

Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth [PDF]

Pharmaceuticals
Background: Topical minoxidil remains the only FDA-approved treatment for hair loss, yet its clinical efficacy is compromised by organic-solvent-induced scalp irritation and poor patient adherence. This study aimed to evaluate natural illite as a carrier
Zhiqing Liu, Wenhua Huang, Shanhua Xu, Meilan Nan, Xian Cui, Yue Wang, Zhehu Jin, Wan Meng, Jingbi Meng, Longquan Pi   +9 more
doaj   +2 more sources

Minoxidil in androgenic alopecia: New formulations with Improved delivery [PDF]

المجلة العراقية للصيدلة, 2022
Background: Minoxidil was introduced into the market as a hypotensive agent, however, aftermarketing, the hypertrichosis side effect was reported by almost all users. This adverse effect encourages the repositioning or repurposing the use of minoxidil as
Alaa Al-taie, Myasar Al-kotaji, Hani Almukhtar   +2 more
doaj   +1 more source

Minoxidil [PDF]

Southern Medical Journal, 1980
Minoxidil (U-10,858) has been shown in several controlled and blind studies and numerous uncontrolled studies to be a potent peripheral vasodilator for use in the management of sustained, severe, accelerating or malignant hypertension and moderate hypertension inadequately controlled by conventional therapy.
  +6 more sources